Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

Clinical Infectious Diseases

Volumn 34, Issue 7, 2002, Pages 909-917

  Marr, Kieren A ^a,b   Carter, Rachel A ^a   Crippa, Fulvio ^a,c   Wald, Anna ^a,b   Corey, Lawrence ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FUNGAL DETECTION; FUSARIUM; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; NEUTROPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCEDOSPORIUM; SURVIVAL RATE;

ADULT; ASPERGILLOSIS; ASPERGILLUS; COHORT STUDIES; FEMALE; FUSARIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MYCOSES; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 0036532203     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339202     Document Type: Article

References (29)

1. Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
2. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial
3. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
4. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management
5. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
6. Dematiaceous fungi are an increasing cause of human disease
7. Zygomycosis in the 1990s in a tertiary care center
8. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
9. Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus
10. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole
11. The new fungal opportunists are coming
12. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
13. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia
14. Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclosphosphamide and total body irradiation with busulfan and cyclosphosphamide
15. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - A prospective, randomized, double-blind study
16. Defining opportunistic invasive fungal infectionsin immunocomprimised patients with cancer and hematopoietic stem cell transplants: An international consensus
17. Nonparametric estimation from incomplete observations
18. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
19. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis
20. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation
21. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation
22. Invasive fungal sinusitis in patients undergoing bone marrow transplantation
23. Zygomycetes in human disease
24. Hematopoietic stem cell transplantation (HSCT) for advanced myelodysplastic syndrome (MDS) after conditioning with busulfan (BU) and fractionated total body irradiation (TBI)
25. Allogeneic marrow transplantation for multiple myeloma: An analysis of risk factors on outcome
26. An EORTC multicenter prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome
27. Infections due to dematiaceous fungi in organ transplant recipients: Case report and review